WELLINGTON MANAGEMENT GROUP LLP - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$78,000
-2.5%
22,708
-19.3%
0.00%
Q3 2019$80,000
-39.8%
28,128
-19.7%
0.00%
Q2 2019$133,000
-53.3%
35,0180.0%0.00%
Q1 2019$285,000
-83.2%
35,018
-82.7%
0.00%
Q1 2017$1,700,000
+133.8%
202,317
-21.0%
0.00%
Q2 2016$727,000
-82.8%
256,120
-82.9%
0.00%
-100.0%
Q1 2016$4,236,000
-94.5%
1,496,859
-80.0%
0.00%
-95.0%
Q4 2015$77,096,000
-9.9%
7,470,439
-0.4%
0.02%
-16.7%
Q3 2015$85,523,000
-18.0%
7,501,936
+7.5%
0.02%
-11.1%
Q2 2015$104,235,000
+64.4%
6,981,571
-0.6%
0.03%
+68.8%
Q1 2015$63,393,000
-29.4%
7,020,283
-5.0%
0.02%
-33.3%
Q4 2014$89,854,000
+56.8%
7,389,273
+26.1%
0.02%
+50.0%
Q3 2014$57,305,000
-16.0%
5,859,426
+9.5%
0.02%
-11.1%
Q2 2014$68,204,000
+60.4%
5,349,345
+33.1%
0.02%
+50.0%
Q1 2014$42,529,000
+16.8%
4,019,761
-16.1%
0.01%
+20.0%
Q4 2013$36,413,000
+90.1%
4,791,230
+82.1%
0.01%
+66.7%
Q3 2013$19,158,0002,631,5900.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$44,153,84752.00%
ORACLE INVESTMENT MANAGEMENT INC 585,194$6,718,0275.60%
Fairmount Funds Management LLC 2,543,107$29,194,8684.63%
Saturn V Capital Management LP 340,163$3,751,0303.11%
TANG CAPITAL MANAGEMENT LLC 1,450,000$16,646,0002.42%
Avoro Capital Advisors LLC 9,050,000$103,894,0001.55%
AlphaCentric Advisors LLC 125,000$1,435,0001.42%
Sarissa Capital Management LP 980,288$11,253,7061.34%
Ghost Tree Capital, LLC 225,000$2,583,0001.10%
SILVERARC CAPITAL MANAGEMENT, LLC 272,173$3,124,5460.89%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders